LivaNova Plc (LIVN)
60.87
-0.46
(-0.75%)
USD |
NASDAQ |
Jan 14, 16:00
60.87
0.00 (0.00%)
After-Hours: 20:00
LivaNova Research and Development Expense (Quarterly): 48.58M for Sept. 30, 2025
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| NovoCure Ltd. | 54.03M |
| Abbott Laboratories | 748.00M |
| Alphatec Holdings, Inc. | 18.68M |
| AtriCure, Inc. | 22.13M |
| iRhythm Technologies, Inc. | 21.03M |